Richebon Menteu Tablets 150 mg (Sodium Risedronate Hemihydrate)

Adult dose

Adults: Administer 150 mg of risedronate sodium orally once a month. No dosage adjustment is necessary in elderly patients (over 60 years of age), since the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. No dosage adjustment is necessary in patients with creatinine clearance of 30 mL/min or higher. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. Because food interferes with the absorption of this medicine, take it at least 30 minutes before the first food or beverage other than water of the day to ensure adequate absorption. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it while in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take this medicine on the scheduled day, take it as follows. If 7 days or more remain until the next scheduled dose, take 1 tablet the next morning after remembering. Take the next dose on the originally scheduled day. Do not take more than 1 tablet of this medicine within 7 days. If fewer than 7 days remain until the next scheduled dose, wait until the originally scheduled day and then take 1 tablet of this medicine.

Child dose

The safety and efficacy in children under 18 years of age have not been established.

This medication may irritate the stomach and esophagus, so individuals with diseases of the esophagus or stomach must consult a doctor before taking it. Especially if symptoms such as esophagitis, esophageal ulcers, or dysphagia occur, stop taking the medication immediately and inform a doctor. This medication should be taken with adequate water, and patients should not lie down for at least 30 minutes after dosing. If the patient cannot sit or stand, this medication should not be taken. Additionally, this medication is not to be administered to individuals with specific genetic metabolic disorders, those with severe kidney impairment, or pregnant or nursing women. In cases of calcium and vitamin D deficiency, it is important to supplement them before taking this medication. During the course of taking this medication, avoid taking other medications or foods that contain calcium, magnesium, iron, etc., and maintain a time gap between doses. Prolonged use may rarely lead to atypical femoral fractures or osteonecrosis of the jaw, so if any unusual symptoms occur, consult a doctor immediately. This medication has not been established as safe for children, and elderly individuals can use it without special precautions. In case of overdose, calcium levels may drop, so immediate medical attention is required. Finally, store this medication out of reach of children and do not transfer it to other containers.

Esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, upper gastrointestinal mucosal irritation, gastric ulcer, duodenal ulcer, indigestion, diarrhea, nausea, abdominal pain, allergic reaction, hypertension, peripheral edema, arthralgia, arthritis, bone trauma, joint abnormalities, myalgia, bone pain, dizziness, depression, insomnia, bronchitis, sinusitis, rhinitis, pharyngitis, increased cough, rash, cataract, urinary tract infection, acute phase reactions (fever, influenza-like symptoms), vomiting, uveitis, sclertitis, iritis, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, angioedema, blister, jawbone necrosis, jaundice, liver dysfunction, loss of appetite, asthenia, heartburn, epigastric pain, discomfort in the chest, palpitations, increased sweating, facial flushing, burning sensation, kidney stones, belching, hematuria, fever, eye pain, atypical femoral fracture, osteonecrosis of the external auditory canal

This medication should be stored in a tightly sealed container to prevent air ingress and should be kept at room temperature between 1 - 30 degrees Celsius. This storage ensures the maintenance of the medication's effectiveness and prevents deterioration.

Appearance

Bright blue rectangular film-coated tablet

Package unit

1 tablet (1 tablet/PTP x 1)